JoVE Logo

Anmelden

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the reabsorption of these drugs can be hindered. When urine becomes alkaline, weak acidic drugs become predominantly ionized. Due to the decreased permeability of ionized forms through tubular cells, these drugs remain in the lumen and are ultimately expelled in the urine. This mechanism, known as 'ion trapping,' prevents reabsorption and enhances renal clearance of unwanted drugs. For example, in cases of phenobarbital overdose—a weak acid—treatment with bicarbonate is used to alkalinize the urine. This action ionizes the drug, impeding its back diffusion. Similarly, when dealing with an overdose of weakly basic drugs such as amphetamines, urine acidification is employed to ensure the ionized drug is not reabsorbed.

Tags

Renal ExcretionTubular ReabsorptionGlomerular FiltrateDistal Convoluted TubuleLipophilic DrugsPassive ReabsorptionDrug IonizationUrine PHIon TrappingRenal ClearancePhenobarbital OverdoseBicarbonate TreatmentUrine AcidificationWeak AcidsWeak Bases

Aus Kapitel 3:

article

Now Playing

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

Pharmacokinetics

3.1K Ansichten

article

3.1 : Pharmakokinetik: Überblick

Pharmacokinetics

5.5K Ansichten

article

3.2 : Absorptionsmechanismus von Medikamenten: Passiver Membrantransport

Pharmacokinetics

3.6K Ansichten

article

3.3 : Absorptionsmechanismus von Medikamenten: Trägervermittelter Membrantransport

Pharmacokinetics

3.5K Ansichten

article

3.4 : Arzneimittelabsorption: Faktoren, die die gastrointestinale Absorption beeinflussen

Pharmacokinetics

3.8K Ansichten

article

3.5 : Bioverfügbarkeit: Überblick

Pharmacokinetics

2.7K Ansichten

article

3.6 : Faktoren, die die Bioverfügbarkeit beeinflussen: First-Pass-Eliminierung

Pharmacokinetics

6.1K Ansichten

article

3.7 : Bioäquivalenz: Überblick

Pharmacokinetics

918 Ansichten

article

3.8 : Effekt "Erster Durchgang"

Pharmacokinetics

5.1K Ansichten

article

3.9 : Zeitverlauf der Arzneimittelwirkung

Pharmacokinetics

1.9K Ansichten

article

3.10 : Wirkstoffverteilung: Gewebebindung

Pharmacokinetics

2.5K Ansichten

article

3.11 : Physiologische Barrieren

Pharmacokinetics

3.4K Ansichten

article

3.12 : Wirkstoffverteilung: Plasmaproteinbindung

Pharmacokinetics

4.8K Ansichten

article

3.13 : Fächermodelle: Modell mit nur einem Fach

Pharmacokinetics

2.1K Ansichten

article

3.14 : Fächermodelle: Modell mit zwei Fächern

Pharmacokinetics

5.2K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten